Agile Therapeutics Inc año OPV
¿Qué es el año OPV de Agile Therapeutics Inc?
El año OPV de Agile Therapeutics Inc es 2014
¿Cuál es la definición de año OPV?
La oferta pública inicial es un tipo de oferta pública en la cual las acciones de una compañía generalmente se venden a inversionistas institucionales que, a su vez, venden al público en general, en una bolsa de valores, por primera vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
año OPV de compañías en Sector Health Care en NASDAQ en comparadas con Agile Therapeutics Inc
¿Qué hace Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Empresas con año opv similar a Agile Therapeutics Inc
- Australian REIT Income Fund tiene año OPV de 2013
- Brookfield Asset Management PRF SH CL A SE37 tiene año OPV de 2013
- Modern Meat tiene año OPV de 2013
- Blue Capital Reinsurance Ltd tiene año OPV de 2013
- Siyata Mobile tiene año OPV de 2013
- Mirati Therapeutics Inc tiene año OPV de 2013
- Agile Therapeutics Inc tiene año OPV de 2014
- Glaukos tiene año OPV de 2015
- UBS ETFs Public - MSCI ACWI SF UCITS ETF tiene año OPV de 2015
- Acasta Enterprises tiene año OPV de 2015
- Faron Pharmaceuticals Oy tiene año OPV de 2015
- GreenPower Motor Co tiene año OPV de 2015
- Sunrun Inc tiene año OPV de 2015